Experimental cancer pharmaceuticals under trial
...is now being evaluated in a Phase I clinical trial in patients with advanced solid tumors. It was discovered and optimized by GSK, in partnership with cytokinetics Inc. ...Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
...sters are related to multiple oncology programs at cytokinetics and will present data evaluating ispinesib, a nove... its collaboration and license agreement with GSK, cytokinetics has assumed responsibility for the costs and activ...sociated with each of these novel drug candidates. cytokinetics plans to conduct at its expense a focused developm...Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
...risen from a broad strategic collaboration between cytokinetics and GlaxoSmithKline (GSK) to discover, develop and...multiple tumor types,? stated Dr. Andrew A. Wolff, cytokinetics Senior Vice President of Clinical Research and Dev... its collaboration and license agreement with GSK, cytokinetics has assumed responsibility for the costs and activ...